LT Group donates anti-COVID vaccines to Pasig City | Inquirer News

LT Group donates anti-COVID vaccines to Pasig City

/ 11:29 AM November 04, 2021

LTG President Michael Tan (left) with Pasig City Mayor Vico Sotto

LTG President Michael Tan (left) with Pasig City Mayor Vico Sotto during the courtesy call

MANILA — LT Group, Inc. (LTG), the holding firm of tycoon Lucio C. Tan, has donated 15,000 doses of AstraZeneca and Moderna vaccines to the people of Pasig City through Mayor Vico Sotto.

In a courtesy call on Wednesday, LTG President Michael G. Tan presented the Deed of Donation to Mayor Sotto covering 10,000 doses of AstraZeneca vaccines administered last August and October and 5,000 doses of Moderna vaccines for use within the next few weeks.

ADVERTISEMENT

Mayor Sotto expressed gratitude to LTG and Tan, saying all vaccines donated by the group were earmarked for persons with disabilities. “Malaking tulong po ito sa ating mga PWDs (This will be a big help to our PWDs),” Mayor Sotto said.

FEATURED STORIES

Earlier, LTG joined some of the country’s biggest conglomerates in ordering AstraZeneca and Moderna vaccines in cooperation with the national government, business advocacy group Go Negosyo led by Presidential Adviser for Entrepreneurship Joey Concepcion and the Razon Group’s ICTSI Foundation.

The Lucio Tan Group of Companies has close to 40,000 employees and 14,000 third party service providers. Aside from inoculating its executives and staff, LTG’s 20 vaccination sites nationwide were also opened to the families and immediate relatives of its employees.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstraZeneca, donation, LT Group, Moderna, Pasig City, Vaccines, Vico Sotto

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.